October 18, 2023

Tsubaki Nakashima Co., Ltd.

Koji Hirota,

Director and Representative Executive Officer CEO

(Code: 6464, Prime, Tokyo Stock Exchange)

Contact for inquiries: Ikunori Morita

Phone: +81 (0)6-6224-0193

Notice of Offering of 17th Share Acquisition Rights and 1st Series Unsecured

Convertible Bonds with Share Acquisition Rights to be Issued Through Third-Party

Allotment

Tsubaki Nakashima Co., Ltd. (the "Company") hereby announces that its Board of Directors, at a meeting held on October 18, 2023, resolved to conduct an offering of share acquisition rights (the "Share Acquisition Rights") and convertible bonds with share acquisition rights (the "Bonds with Share Acquisition Rights," and the bonds thereof are hereinafter referred to as the "Bonds," and the share acquisition rights attached thereto are hereinafter referred to as the "Convertible Bond-Type Share Acquisition Rights") to be issued through a third-party allotment. The details are described below.

Please also refer to the "Notice of Business Alliance" dated today.

1. Overview of Offering 17th Share Acquisition Rights

(1)

Allotment date

November 9, 2023

Under the Subscription Agreement (as defined below), the Scheduled

Allottee agrees to pay the total amount of issue price on the due date of

payment provided that the conditions set out in the Subscription

Agreement are satisfied.

(2)

Total number of share

62,814 acquisition rights (466 yen per Share Acquisition Right)

acquisition rights

(3)

Issue price of Share

29,271,324 yen in total

Acquisition Rights

(4)

Number of dilutive

Number of dilutive shares at the initial exercise price (796 yen):

shares resulting from

6,281,400 shares

issuance

Number of dilutive shares at the Floor Exercise Price (676 yen):

7,396,441 shares

(5)

Amount of funds to be

5,029,265,724 yen (estimated net proceeds:

5,024,265,724 yen)

procured

(Note)

(Breakdown)

Issuance of the Share Acquisition Rights:

29,271,324 yen

Exercise of the Share Acquisition Rights:

4,999,994,400 yen

(6)

Exercise price

796 yen per share

If the average closing price (rounded up to the nearest yen; the

"Revision Date Price") of the common shares of the Company in

regular trading on the Tokyo Stock Exchange, Inc. (the "TSE") over the

This press release has been prepared for the purpose of publicly announcing the issuance by the Company of share acquisition rights and convertible bonds with share acquisition rights by way of third-party allotment, and not for the purpose of soliciting investment or engaging in any other similar activities.

The forecasts, estimations, prospects and other information pertaining to future outcomes included in this press release are based on the information available to the Company as of today and certain conditions or assumptions, and the actual operating results, etc. may differ significantly from the information pertaining to future outcomes included in this press release due to domestic and foreign financial conditions, foreign exchange trends, or other risk factors.

1

20 consecutive trading days ending on (and including) May 9, 2024, May 9, 2025, and May 9, 2026 (individually or collectively, the "Revision Date") is lower than the exercise price effective on the Revision Date by one yen or more, the exercise price shall be revised to the Revision Date Price from the Revision Date onward. However, if the amount obtained as a result of the above calculation is less than the Floor Exercise Price (as defined below), the revised exercise price shall be the Floor Exercise Price. The "Floor Exercise Price" shall be 676 yen (the product of the initial exercise price multiplied by 85%.)

(7)

Method of offering or

By way of third-party allotment

allotment

(8)

Scheduled allotee

AAGS S6, L.P.

(9)

Other Matters

The

Company will today execute the subscription agreement (the

"Subscription Agreement") regarding the Share Acquisition

Rights and Bonds with the Share Acquisition Rights with AAGS

S6, L.P. (the "Scheduled Allotee"). The following matters will

be set out in the Subscription Agreement. The date on which

the Share Acquisition Rights will be allotted to the Scheduled

Allottee is November 9, 2023.

(i)

The Scheduled Allotee will not exercise the Share Acquisition

Rights from November 10, 2023 to May 9, 2024.

(ii)

Notwithstanding (i), if (A) an early redemption event prescribed

in the terms and conditions occurs, (B) it is discovered that the

conditions precedent provided for in the Subscription Agreement

are not satisfied on the due date of payment, (C) the Company

agrees to the exercise of the Share Acquisition Rights by the

Scheduled Allottee, (D) trading of the common shares of the

Company on the TSE has been suspended for a period of five

trading days or more, (E) the Company is in material breach of

any of its obligations, representations, or warranties under the

Subscription Agreement, or (F) the Company fails to lawfully

submit the Annual Securities Report or Quarterly Securities

Report, the Scheduled Allottee may exercise the Share

Acquisition Rights at any time thereafter.

(iii)

The following matters will be set out in the Subscription

Agreement. For further information, please refer to "(5) First

Refusal Right" and "(6) Put options regarding the Share

Acquisition Rights" under "6. Reason for Selection of Scheduled

Allottee, Etc." below.

-

First refusal right

-

Put options regarding the Share Acquisition Rights

Note:

The amount of funds to be procured shall be the aggregate amount of total issue price of the Share

Acquisition Rights and the exercise price calculated on the assumption that all of the Share Acquisition

Rights are exercised at the initial exercise price. If the Share Acquisition Rights are not exercised

within the exercise period of the Share Acquisition Rights or cancelled by the Company, the amount of

funds procured will decrease.

1st Series Unsecured Convertible Bonds with Share Acquisition Rights

(1) Due date of payment

November 9,

2023

The allotment date of the Bonds with Share Acquisition Rights is

November 9,

2023.

Under the Subscription Agreement, the Scheduled Allottee agrees to

pay the total amount of issue price on the due date of payment provided

This press release has been prepared for the purpose of publicly announcing the issuance by the Company of share acquisition rights and convertible bonds with share acquisition rights by way of third-party allotment, and not for the purpose of soliciting investment or engaging in any other similar activities.

The forecasts, estimations, prospects and other information pertaining to future outcomes included in this press release are based on the information available to the Company as of today and certain conditions or assumptions, and the actual operating results, etc. may differ significantly from the information pertaining to future outcomes included in this press release due to domestic and foreign financial conditions, foreign exchange trends, or other risk factors.

2

that the conditions set out in the Subscription Agreement are satisfied.

(2) Total number of share

40 acquisition rights

acquisition rights

(3) Issue price of Bonds and

100.2 yen per 100 yen of each Bond

Share Acquisition Rights

However, no payment in exchange for the Convertible Bond-Type

Share Acquisition Rights is required.

(4)

Number of dilutive

Number of dilutive shares at the initial conversion price (796 yen):

shares resulting from

12,562,800 shares

issuance

Number of dilutive shares at the Floor Conversion Price (676 yen):

14,792,800 shares

(5) Amount of funds to be

10,020,000,000 yen (estimated net proceeds: 10,010,000,000 yen)

procured

(6)

Exercise price or

796 yen per share

conversion price

If the average closing price (the Revision Date Price) of the common

shares of the Company in regular trading on the TSE over the 20

consecutive trading days ending on (and including) May 9, 2024, May

9, 2025, and May 9, 2026 (the Revision Date) is lower than the

conversion price effective on the Revision Date by one yen or more, the

conversion price shall be revised to the Revision Date Price from the

Revision Date onward. However, if the amount obtained as a result of

the above calculation is less than the Floor Conversion Price (as defined

below), the revised conversion price shall be the Floor Conversion

Price. The "Floor Conversion Price" shall be 676 yen (the product of

the initial conversion price multiplied by 85%.)

(7) Method of offering or

By way of third-party allotment

allotment

(8)

Scheduled allotee

AAGS S6, L.P.

(9)

Other Matters

The Company will today execute the Subscription Agreement regarding

the Share Acquisition Rights and Bonds with the Share Acquisition

Rights with the Scheduled Allotee. The date on which the Bonds with

the Share Acquisition Rights will be allotted to the Scheduled Allottee

is November 9, 2023.

(i)

The Scheduled Allottee shall not exercise the Convertible Bond-

Type Share Acquisition Rights if the closing price of the common

shares of the Company in regular trading on the trading day

immediately prior to the date on which the Scheduled Allotee

intends to request to exercise the Convertible Bond-Type Share

Acquisition Rights (if no closing price is available for the last

trading day before that day, then the closing price on the most

recent trading day prior to that day) is lower than the product of

the conversion price effective on the day on which the Scheduled

Allotee intends to request to exercise the Convertible Bond-Type

Share Acquisition Rights multiplied by 1.2 (rounded down to the

nearest whole yen). However, if the Scheduled Allottee intends

to request to exercise the Convertible Bond-Type Share

Acquisition Rights, the Scheduled Allottee may convert the

Convertible Bond-Type Share Acquisition Rights to the extent

that (A) the cumulative number of common shares of the

Company to be acquired by such conversion and the cumulative

number of common shares of the Company acquired by the

Scheduled Allottee by the time of such conversion does not

exceed (B) the cumulative number of common shares of the

Company sold by the Scheduled Allottee by the time of such

conversion (including the case where the cumulative number in

This press release has been prepared for the purpose of publicly announcing the issuance by the Company of share acquisition rights and convertible bonds with share acquisition rights by way of third-party allotment, and not for the purpose of soliciting investment or engaging in any other similar activities.

The forecasts, estimations, prospects and other information pertaining to future outcomes included in this press release are based on the information available to the Company as of today and certain conditions or assumptions, and the actual operating results, etc. may differ significantly from the information pertaining to future outcomes included in this press release due to domestic and foreign financial conditions, foreign exchange trends, or other risk factors.

3

  1. (A) exceeds the cumulative number in (B), but the excess number is lower that the number of common shares of the Company to be acquired in exchange for one Convertible Bond-Type Share Acquisition Right that is effective on the day on which the Scheduled Allottee intends to request to exercise the Convertible Bond-Type Share Acquisition Rights).

  2. Notwithstanding (i), if (A) an early redemption event prescribed in the terms of issue occurs, (B) it is discovered that the conditions precedent provided for in the Subscription Agreement are not satisfied on the due date of payment, (C) the Company agrees to the exercise of the Convertible Bond-Type Share Acquisition Rights by the Scheduled Allottee, (D) trading of the common shares of the Company on the TSE has been suspended for a period of five trading days or more, (E) the Company is in material breach of any of its obligations, representations, or warranties under the Subscription Agreement, or (F) the Company fails to lawfully submit the Annual Securities Report or Quarterly Securities Report, the Scheduled Allottee may exercise the Convertible Bond-Type Share Acquisition Rights at any time thereafter.
  3. The following matters will be set out in the Subscription Agreement. For further information, please refer to "(5) First Refusal Right" under "6. Reason for Selection of Scheduled Allottee, Etc." below.
    • First refusal right

2. Purpose of and Reasons for Offering

The Company's group (the "Group") consists of the Company and 22 domestic and overseas consolidated subsidiaries that manufacture and sell precision balls, precision rollers, ball screws, blowers, and other precision components. As a manufacturing company, the Group places "safety, quality, and environment" at the top of its management priorities and seeks to carry out its business activities in harmony with society, local communities, and nature. The Group is accelerating the globalization of medical products and other products that meet the needs for high-quality healthcare in response to the COVID-19 and the aging of the population toward the realization of a decarbonized society in the future. The Group is working daily to steadily implement its management strategy, achieve further profitable growth, and become a shining company that continues to create corporate value. In addition, the Group has formulated a Mid-Term Strategy "Transform Next 2023," which ends in the fiscal year ending December 31, 2023, and aims to become a "Best in Class" manufacturing company that engages in "base technology innovation," "Monozukuri innovation," "generating cash to execute strategic investments," and other initiatives.

Under these circumstances, the Group's current management policies include: (A) strengthening sales by reviewing unprofitable products and other measures and restoring earning power by rebuilding the U.S. and linear businesses, and (B) improving development speed, streamlining and strengthening development resources, investing in human resources, and strengthening DX initiatives in order to become a "Best in Class" manufacturing company. The Group believes that the realization of these goals will lead to an increase in the corporate value of the Group.

The Company concluded that, in order to ensure the implementation of the above measures, it would be effective to combine its own resources with external alliances to raise the necessary funds and carry out the measures. It then received a proposal from Advantage Advisors Co., Ltd. (Address: Toranomon Towers Office 4-1-28 Toranomon, Minato-ku Tokyo; Representative Director: Taisuke Sasanuma; "Advantage Advisors"), to provide various types of business support to the Group, as well as information, customer referrals, and financing through Advantage Advisors' group network. Since around May 2023, the Company has continued discussions with Advantage Advisors while exchanging information and holding

This press release has been prepared for the purpose of publicly announcing the issuance by the Company of share acquisition rights and convertible bonds with share acquisition rights by way of third-party allotment, and not for the purpose of soliciting investment or engaging in any other similar activities.

The forecasts, estimations, prospects and other information pertaining to future outcomes included in this press release are based on the information available to the Company as of today and certain conditions or assumptions, and the actual operating results, etc. may differ significantly from the information pertaining to future outcomes included in this press release due to domestic and foreign financial conditions, foreign exchange trends, or other risk factors.

4

meetings with them, and after careful consideration of Advantage Advisors' specific proposal as well as their track record of support for multiple listed companies, the Company determined that forming a business alliance with Advantage Advisors and issuing share acquisition rights and convertible bonds with share acquisition rights by way of a third-party allotment to a fund serviced by Advantage Advisors is the most appropriate proposal to enhance the corporate value of the Group, on the basis that (i) in addition to Advantage Advisors' extensive consulting experience, they will be able to provide high-level management support as the Company addresses the business challenges it has identified, and (ii) the issuance of the Share Acquisition Rights and the Bonds with Share Acquisition Rights by way of a third-party allotment as proposed by Advantage Advisors is the most suitable fund-raising method for the Company, as described in "Reasons for selecting financing through share acquisition rights and convertible bonds with share acquisition rights" in "(2) Specific use of funds to be procured" in "3. Amount of funds to be procured, purpose of use, and scheduled timing of expenditure" below. As such, the Company determined at the Board of Directors meeting held today to enter into a business alliance with Advantage Advisors.

3. Amount of funds to be procured, purpose of use, and scheduled timing of expenditure

  1. Amount of funds to be procured (estimated net proceeds)

Total amount to be paid in (yen)

Estimated amount of issuance

Estimated net proceeds (yen)

costs (yen)

15,049,265,724

15,000,000

15,034,265,724

Note: 1. Consumption taxes and the like are not included in the estimated amount of issuance costs.

    1. Issuance costs are mainly comprised of fiscal agent fees, attorney's fees, third-party appraiser fees, expenses for investigating anti-social forces, other administrative expenses (printing service expenses, registration expenses), and the like.
    2. The total amount to be paid in is calculated on the assumption that all of the Share Acquisition Rights are exercised. If the Share Acquisition Rights are not exercised within the exercise period or the Share Acquisition Rights acquired by the Company are cancelled, the total amount to be paid in and the estimated net proceeds will decrease.
    3. The estimated amount of issuance costs is the sum of the estimated amount of issuance costs for the Share Acquisition Rights (5,000,000 yen) and the estimated amount of issuance costs for the Bonds with Share Acquisition Rights (10,000,000 yen), and the estimated net proceeds is the sum of the estimated net proceeds for the Share Acquisition Rights (5,024,265,724 yen) and the estimated net proceeds for the Bonds with Share Acquisition Rights (10,010,000,000 yen).
  1. Specific use of funds to be procured

In respect of the 15,034,265,724 yen of the abovementioned estimated next proceeds (5,024,265,724 yen from the Share Acquisition Rights and 10,010,000,000 yen from the Bonds with Share Acquisition Rights), the funds for increasing production, improving quality, and enhancing profitability are scheduled to be allocated by no later than October 2028. The specific breakdown of such funds is as follows.

Until their actual expenditure, the procured funds will be securely managed as in the bank accounts of the Company.

In respect of the 10,010,000,000 yen of the estimated next proceeds that pertain to the Bonds with Share Acquisition Rights, the funds are scheduled to be allocated mainly to (A) capital expenditure to increase production of ceramic balls, steel balls, and medical parts, (B) capital expenditure to supply high quality products, (C) capital expenditure to improve profitability in the U.S. Business by changing work schedules, streamlining logistics, and incorporating high value-added products, and (D) capital expenditure to improve thermal efficiency, switch from fossil fuels to electric energy, and expand solar installation. In respect of the 5,024,265,724 yen of the estimated next proceeds that pertain to the Share Acquisition Rights, the funds are scheduled to be allocated mainly to (A) capital expenditure to increase production of ceramic balls, steel balls, and medical parts, (B) capital expenditure to supply high quality products, and (D) capital expenditure to improve thermal efficiency, switch from fossil fuels to electric energy, and expand solar installation.

This press release has been prepared for the purpose of publicly announcing the issuance by the Company of share acquisition rights and convertible bonds with share acquisition rights by way of third-party allotment, and not for the purpose of soliciting investment or engaging in any other similar activities.

The forecasts, estimations, prospects and other information pertaining to future outcomes included in this press release are based on the information available to the Company as of today and certain conditions or assumptions, and the actual operating results, etc. may differ significantly from the information pertaining to future outcomes included in this press release due to domestic and foreign financial conditions, foreign exchange trends, or other risk factors.

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Tsubaki Nakashima Co. Ltd. published this content on 18 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 October 2023 07:11:36 UTC.